Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Calidi Biotherapeutics, Inc. (CLDI) had Weighted-Average Shares Outstanding (Diluted) of 1.42M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.16M |
|
-- |
|
-- |
|
$4.15M |
|
$-4.15M |
|
$-0.01M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.15M |
|
$-3.71M |
|
1.42M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.42M |
$-2.94 |
|
$-2.94 |
|
| Balance Sheet Financials | |
$5.43M |
|
$0.78M |
|
$1.78M |
|
$7.20M |
|
$3.24M |
|
$0.76M |
|
$0.83M |
|
$4.07M |
|
$3.13M |
|
$3.13M |
|
$3.13M |
|
2.08M |
|
| Cash Flow Statement Financials | |
$-8.47M |
|
$-0.04M |
|
$6.99M |
|
$5.82M |
|
$4.29M |
|
$-1.53M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
0.20 |
|
0.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-132.78% |
|
-132.78% |
|
-57.75% |
|
-106.83% |
|
$1.50 |
|
$-6.01 |
|
$-5.98 |
|